205 related articles for article (PubMed ID: 19124504)
1. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.
Setiawan VW; Doherty JA; Shu XO; Akbari MR; Chen C; De Vivo I; Demichele A; Garcia-Closas M; Goodman MT; Haiman CA; Hankinson SE; Henderson BE; Horn-Ross PL; Lacey JV; Le Marchand L; Levine DA; Liang X; Lissowska J; Lurie G; McGrath M; Narod SA; Rebbeck TR; Ursin G; Weiss NS; Xiang YB; Yang HP; Zheng W; Olson SH
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):242-7. PubMed ID: 19124504
[TBL] [Abstract][Full Text] [Related]
2. CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer.
Thompson DJ; O'Mara TA; Glubb DM; Painter JN; Cheng T; Folkerd E; Doody D; Dennis J; Webb PM; ; Gorman M; Martin L; Hodgson S; ; Michailidou K; Tyrer JP; Maranian MJ; Hall P; Czene K; Darabi H; Li J; Fasching PA; Hein A; Beckmann MW; Ekici AB; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Zhao H; Depreeuw J; Schrauwen S; Amant F; Goode EL; Fridley BL; Dowdy SC; Winham SJ; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Ashton K; Proietto T; Otton G; Carvajal-Carmona L; Tham E; Liu T; Mints M; ; Scott RJ; McEvoy M; Attia J; Holliday EG; Montgomery GW; Martin NG; Nyholt DR; Henders AK; Hopper JL; Traficante N; ; Ruebner M; Swerdlow AJ; Burwinkel B; Brenner H; Meindl A; Brauch H; Lindblom A; Lambrechts D; Chang-Claude J; Couch FJ; Giles GG; Kristensen VN; Cox A; Bolla MK; Wang Q; Bojesen SE; Shah M; Luben R; Khaw KT; Pharoah PD; Dunning AM; Tomlinson I; Dowsett M; Easton DF; Spurdle AB
Endocr Relat Cancer; 2016 Feb; 23(2):77-91. PubMed ID: 26574572
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.
Tao MH; Cai Q; Zhang ZF; Xu WH; Kataoka N; Wen W; Xiang YB; Zheng W; Shu XO
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):943-9. PubMed ID: 17507620
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
Haiman CA; Dossus L; Setiawan VW; Stram DO; Dunning AM; Thomas G; Thun MJ; Albanes D; Altshuler D; Ardanaz E; Boeing H; Buring J; Burtt N; Calle EE; Chanock S; Clavel-Chapelon F; Colditz GA; Cox DG; Feigelson HS; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn JN; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Le Marchand L; Lenner P; Lund E; Panico S; Peeters PH; Pike MC; Riboli E; Tjonneland A; Travis R; Trichopoulos D; Wacholder S; Ziegler RG
Cancer Res; 2007 Mar; 67(5):1893-7. PubMed ID: 17325027
[TBL] [Abstract][Full Text] [Related]
5. Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk.
Goodman MT; Lurie G; Thompson PJ; McDuffie KE; Carney ME
Endocr Relat Cancer; 2008 Dec; 15(4):1055-60. PubMed ID: 18667686
[TBL] [Abstract][Full Text] [Related]
6. Interaction between CYP19A1 polymorphisms and body mass index in the risk of endometrial cancer in postmenopausal Japanese women.
Hosono S; Matsuo K; Ito H; Watanabe M; Hirose K; Nakanishi T; Tajima K; Tanaka H
Asian Pac J Cancer Prev; 2011; 12(10):2747-52. PubMed ID: 22320986
[TBL] [Abstract][Full Text] [Related]
7. Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer.
Xu WH; Dai Q; Xiang YB; Long JR; Ruan ZX; Cheng JR; Zheng W; Shu XO
Am J Epidemiol; 2007 Dec; 166(12):1420-30. PubMed ID: 17827443
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.
Terry K; McGrath M; Lee IM; Buring J; De Vivo I
Gynecol Oncol; 2010 May; 117(2):255-9. PubMed ID: 20199803
[TBL] [Abstract][Full Text] [Related]
9. Haplotype structures and functional polymorphic variants of the drug target enzyme aromatase (CYP19A1) in South Indian population.
Umamaheswaran G; Dkhar SA; Kalaivani S; Anjana R; Revathy M; Jaharamma M; Shree KM; Kadambari D; Adithan C
Med Oncol; 2013; 30(3):665. PubMed ID: 23893151
[TBL] [Abstract][Full Text] [Related]
10. CYP19 (aromatase) haplotypes and endometrial cancer risk.
Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I
Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
12. Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.
Yang HP; Gonzalez Bosquet J; Li Q; Platz EA; Brinton LA; Sherman ME; Lacey JV; Gaudet MM; Burdette LA; Figueroa JD; Ciampa JG; Lissowska J; Peplonska B; Chanock SJ; Garcia-Closas M
Carcinogenesis; 2010 May; 31(5):827-33. PubMed ID: 20053928
[TBL] [Abstract][Full Text] [Related]
13. Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Tang L; Platek ME; Yao S; Till C; Goodman PJ; Tangen CM; Wu Y; Platz EA; Neuhouser ML; Stanczyk FZ; Reichardt JKV; Santella RM; Hsing A; Figg WD; Lippman SM; Thompson IM; Ambrosone CB
Carcinogenesis; 2018 Feb; 39(2):125-133. PubMed ID: 29228205
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in CYP17 and endometrial cancer risk.
Gaudet MM; Lacey JV; Lissowska J; Peplonska B; Brinton LA; Chanock S; Garcia-Closas M
Hum Genet; 2008 Mar; 123(2):155-62. PubMed ID: 18172694
[TBL] [Abstract][Full Text] [Related]
15. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review.
Olson SH; Bandera EV; Orlow I
Am J Epidemiol; 2007 Feb; 165(3):235-45. PubMed ID: 17110639
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.
Lee E; Hsu C; Haiman CA; Razavi P; Horn-Ross PL; Van Den Berg D; Bernstein L; Le Marchand L; Henderson BE; Setiawan VW; Ursin G
Carcinogenesis; 2010 Aug; 31(8):1392-9. PubMed ID: 20547493
[TBL] [Abstract][Full Text] [Related]
17. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
18. Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study.
Boone SD; Baumgartner KB; Baumgartner RN; Connor AE; Pinkston CM; Rai SN; Riley EC; Hines LM; Giuliano AR; John EM; Stern MC; Torres-Mejía G; Wolff RK; Slattery ML
Cancer Causes Control; 2014 Nov; 25(11):1461-71. PubMed ID: 25088806
[TBL] [Abstract][Full Text] [Related]
19. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
Travis RC; Schumacher F; Hirschhorn JN; Kraft P; Allen NE; Albanes D; Berglund G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Calle EE; Chanock S; Dunning AM; Hayes R; Feigelson HS; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Kaaks R; Kolonel LN; Ma J; Rodriguez L; Riboli E; Stampfer M; Stram DO; Thun MJ; Tjønneland A; Trichopoulos D; Vineis P; Virtamo J; Le Marchand L; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2734-44. PubMed ID: 19789370
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the androgen receptor gene and endometrial cancer risk.
Yang HP; Garcia-Closas M; Lacey JV; Brinton LA; Lissowska J; Peplonska B; Chanock S; Gaudet MM
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):585-9. PubMed ID: 19190146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
